NCT06084923 2024-04-10Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease ProgressionGruppo Italiano Malattie EMatologiche dell'AdultoNot yet recruiting73 enrolled